Clinical studies recruiting near Cangzhou

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
Phase 2 · Cangzhou Central Hospital · Kunming Pharmaceuticals, Inc. · NCT07279493 A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · Cangzhou Central Hospital · Shanghai Henlius Biotech · NCT07160335 Explore the Diagnostic Value of Bronchodilation Test With Portable Oscillometry in Asthma Diagnosis
NA · Research Site · AstraZeneca · NCT07516184 A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathie
Phase 3 · Cangzhou People's Hospital · Pfizer · NCT05895786 Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
Phase 3 · Cangzhou combination of Chinese traditional and western medi · Capital Medical University · NCT06548971 A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carc
Phase 3 · CangZhou Center Hospital · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06860971 Normobaric Oxygen in AIS Transferred for EVT
Phase 3 · Cangzhou Central Hospital · Capital Medical University · NCT06666764 Desflurane vs. Propofol for Cardiac Anesthesia
Phase 3 · Cangzhou People's Hospital · Xijing Hospital · NCT07116733 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Comp
Phase 3 · Research Site · AstraZeneca · NCT07662044 Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps
Phase 3 · Cangzhou Central Hospital · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT07107256 Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema
Phase 3 · Cangzhou Central Hospital · Bio-Thera Solutions · NCT07515079 Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy（RECAST-MT）
Phase 3 · Cangzhou Central Hospital · Capital Medical University · NCT06559241 A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2)
Phase 3 · Cangzhou Central Hospital · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT07043725 RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Smal
Phase 3 · Cangzhou Central Hospital · RemeGen Co., Ltd. · NCT07416474 Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)
NA · Cangzhou Central Hospital · Harbin Medical University · NCT07567625 A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)
Phase 1/Phase 2 · Cangzhou People's Hosipital · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT06122831 A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection
Phase 1/Phase 2 · Cangzhou Central hospital · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT07367529 A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab
Phase 3 · Research Site · AstraZeneca · NCT07520162 PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis
Phase 4 · Cangzhou Hospital of Integrated Traditional Chinese and West · Peking Union Medical College Hospital · NCT06902740 A Study of Ziresovir (AK0529) in High-risk Adult With Respiratory Syncytial Virus (RSV) Infection.
Phase 2/Phase 3 · Cangzhou Hospital of Integrated TCM-WM · Shanghai Ark Biopharmaceutical Co., Ltd. · NCT07658534 Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors
Phase 2 · Hebei Province Cangzhou Hospital of Integrated Traditional a · Tianjin Medical University Cancer Institute and Hospital · NCT07058948 Modified Tumor-free Techniques Operation to Cervical Cancer
NA · Cangzhou Central Hospital · Peking Union Medical College Hospital · NCT06836869 A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events i
Phase N/A · Cangzhou Central Hospital · Amgen · NCT06295679 A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma
Phase 1 · Cangzhou Central Hospital · Betta Pharmaceuticals Co., Ltd. · NCT05341557 TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
Phase 3 · Cangzhou Hospital of Integrated TCM-WM·Hebei · Shanghai Chia Tai Tianqing Pharmaceutical Technology Develop · NCT06829784 A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in
Phase 1 · Cangzhou People's Hospital · Shanghai Henlius Biotech · NCT07477587 Furmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients
Phase 2 · CANGZHOU People's Hospital · Tianjin Medical University Cancer Institute and Hospital · NCT07304739 A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Pe
Phase 3 · Hebei Cangzhou Central Hospital · Boehringer Ingelheim · NCT07361302 Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative Dementia
Phase N/A · Cangzhou Hospital of Integrated Traditional Chinese and West · Ruijin Hospital · NCT06534658

Look up another city

Look up another condition